# Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study

> **NCT02007317** · PHASE2 · COMPLETED · sponsor: **Oshadi Drug Administration** · enrollment: 30 (actual)

## Conditions studied

- BCC

## Interventions

- **DRUG:** Oshadi D & Oshadi R

## Key facts

- **NCT ID:** NCT02007317
- **Lead sponsor:** Oshadi Drug Administration
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02007317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02007317, "Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02007317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*